VISCHER advised Novaremed AG on the deal.Novaremed AG, a privately held clinical-stage biopharmaceutical company and NeuroFront Therapeutics (Hong Kong) Limited, a China-based clinical stage neuroscience biotech…
Novaremed’s Option and License Agreement With NeuroFront
![](https://globallegalchronicle.com/wp-content/uploads/2022/08/novaremeds-option-and-license-agreement-with-neurofront_62eb6753db64f-480x360.jpeg)